Biomarker-driven molecular imaging probes in radiotherapy

H Li, Q Gong, K Luo - Theranostics, 2024 - pmc.ncbi.nlm.nih.gov
Background: Biomarker-driven molecular imaging has emerged as an integral part of cancer
precision radiotherapy. The use of molecular imaging probes, including nanoprobes, have …

Towards Effective Targeted Alpha Therapy for Neuroendocrine Tumours: A Review

PMD Gape, MK Schultz, GJ Stasiuk, SYA Terry - Pharmaceuticals, 2024 - mdpi.com
This review article explores the evolving landscape of Molecular Radiotherapy (MRT),
emphasizing Peptide Receptor Radionuclide Therapy (PRRT) for neuroendocrine tumours …

Identifying and navigating bottlenecks in the translation of novel radiopharmaceuticals: a perspective

M Schottelius - European Journal of Nuclear Medicine and Molecular …, 2024 - Springer
The field of nuclear theranostics has experienced a true boost in recent years, fueled by
robust scientific advances in tracer development. Clinical trials have confirmed the value of …